Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels

Journal of Vascular Surgery

Volumn 35, Issue 1, 2002, Pages 137-145

  Grønholdt, Marie Louise M ^a,e   Nordestgaard, Børge G ^b   Bentzon, Jacob ^c   Wiebe, Britt M ^a   Zhou, Ji ^c   Falk, Erling ^c   Sillesen, Henrik ^d  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; AUTACOID; FIBRINOLYTIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BLEEDING; CALCIFICATION; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; LIPID BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; BLOOD; CAROTID ARTERY DISEASE; DRUG EFFECT; ECHOGRAPHY; LUMINESCENCE; MIDDLE AGED; PATHOLOGY;

ANALYSIS OF VARIANCE; ASPIRIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; LUMINESCENT MEASUREMENTS; MACROPHAGES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES;

EID: 0010528179     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.119042     Document Type: Article

References (36)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. De Boer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation, and infection. J Pathol 2000;190:237-43.
3. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. part 1. N Engl J Med 1992;326:242-50.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes, part 2. N Engl J Med 1992;326:310-8.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
7. Mauricllo A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR Jr, Schwartz RS, et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 2000;101:744-50.
8. Gronholdt MLM, Nordestgaard BG, Wiebe BM, Wilhjelm JE, Sillesen H. Echolucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998;97:34-40.
9. El-Atrozy T, Nicolaides A, Tegos T, Zarka AZ, Griffin M, Sabetai M. The effect of B-mode image standardisation on the echodensity of symptomatic and asymptomatic carotid bifurcation plaques. Int J Angiol 1998;17:179-86.
10. Falk E, Fuster V, Shah PK. Interrelationship between atherosclerosis and thrombosis. In: Lippincott-Raven Publishers, 2nd ed., Cardiovascular Thombosis: Thrombocardiology and Thromboneurology, Philadelphia 1998;45-58.
11. Dirksen MT, van der Wal AC, van den Berg FM, Van der Loos CM, Becker AE. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998;98:2000-3.
12. Carr SC, Farb A, Pearce WH, Virmani R, Yao JST. Activated inflammatory cells arc associated with plaque rupture in carotid artery stenosis. Surgery 1997;122:757-64.
13. Pasterkamp G, Schoneveld AH, van der Wal AC, Haudenschild CC, Clarijs RJG, Becker AE, et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. JACC 1998;32:655-62.
14. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92:1084-8.
15. Milei J, Parodi JC, Alonso GF, Barone A, Grana D, Matturi L. Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. Am Heart J 1998;136:1096-105.
16. Gronholdt MLM. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 1999;19:2-13.
17. Polak JF, Shemanski L, O'Leary DU, Lefkowitz D, Price TR, Savage PJ, et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998;208:649-54.
18. Gronholdt MLM, Nordestgaard BN, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future stroke. Circulation 2001;104:68-73.
19. Carr S, Farb A, Pearce WH, Virmani R, Yao JST. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996;23:755-66.
20. Jander S, Sitzer M, Schumann R, Schroeter M, Siebler M, Steinmetz H, et al. Inflammation in high-grade carotid stenosis. A possible role for macrophages and T cells in plaque destabilization. Stroke 1998;29:1625-30.
21. Bassiouny HS, Sakaguchi Y, Mikucki SA, Mckinsey JF, Piano G, Gewertz BL, et al. Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 1997;26:585-94.
22. Lusby RJ, Ferrell LD, Ehrenfeld WK, Stoney RJ, Wylie EJ. Carotid plaque hemorrhage. Arch Surg 1982;117:1479-88.
23. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effects of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998;97:2110-6.
24. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998;97:2433-44.
25. Weber C, Erl W, Weber KS, Weber PC. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 1997;30:1212-7.
26. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279:1643-50.
27. Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 1985;72:1177-84.
28. Page CP. Platelets as inflammatory cells. Immunopharmacology 1989;17:51-9.
29. Weber C, Erl W, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-kappa E mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995;91:1914-7.
30. Ikonomidis I, Andrcotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-8.
31. Claria J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995;92:9475-9.
32. Schrör K. Aspirin and platelets. The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997;23:349-56.
33. Ranke C, Hecker H, Creutzig A, Alexander K. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation 1993;87:1873-9.
34. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink G, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
35. Danesh J, Collins R, Appleby P, Peto R. Associations of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
36. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E, for the Cholesterol and Recurrent Events (CARE) Investigators. Long-term effect of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-5.